These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 38959352)
1. Integrative Multiomics Analyses Identify Molecular Subtypes of Head and Neck Squamous Cell Carcinoma with Distinct Therapeutic Vulnerabilities. Diao P; Dai Y; Wang A; Bu X; Wang Z; Li J; Wu Y; Jiang H; Wang Y; Cheng J Cancer Res; 2024 Sep; 84(18):3101-3117. PubMed ID: 38959352 [TBL] [Abstract][Full Text] [Related]
2. Multi omics analysis of mitophagy subtypes and integration of machine learning for predicting immunotherapy responses in head and neck squamous cell carcinoma. Liu J; Li H; Dong Q; Liang Z Aging (Albany NY); 2024 Jun; 16(12):10579-10614. PubMed ID: 38913914 [TBL] [Abstract][Full Text] [Related]
3. Integrative Analysis of Multi-omics Data Identified EGFR and PTGS2 as Key Nodes in a Gene Regulatory Network Related to Immune Phenotypes in Head and Neck Cancer. Feng B; Shen Y; Pastor Hostench X; Bieg M; Plath M; Ishaque N; Eils R; Freier K; Weichert W; Zaoui K; Hess J Clin Cancer Res; 2020 Jul; 26(14):3616-3628. PubMed ID: 32161122 [TBL] [Abstract][Full Text] [Related]
4. Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer. Saleh AD; Cheng H; Martin SE; Si H; Ormanoglu P; Carlson S; Clavijo PE; Yang X; Das R; Cornelius S; Couper J; Chepeha D; Danilova L; Harris TM; Prystowsky MB; Childs GJ; Smith RV; Robertson AG; Jones SJM; Cherniack AD; Kim SS; Rait A; Pirollo KF; Chang EH; Chen Z; Van Waes C Clin Cancer Res; 2019 May; 25(9):2860-2873. PubMed ID: 30723145 [TBL] [Abstract][Full Text] [Related]
5. Identification of Immune Subtypes for Predicting the Prognosis of Patients in Head and Neck Squamous Cell Carcinoma. Sun J; Fang G; Zuo Z; Yu X; Xue L; Li C; Li S Technol Cancer Res Treat; 2021; 20():15330338211045823. PubMed ID: 34657509 [TBL] [Abstract][Full Text] [Related]
6. Identification of immunogenic cell death-related damage-related molecular patterns (DAMPs) to predict outcomes in patients with head and neck squamous cell carcinoma. Zhang J; Shi X; Wang M; Zhai R; Wang M; Gong Z; Ni Z; Xu T; Zhu W; Liu L J Cancer Res Clin Oncol; 2024 May; 150(5):240. PubMed ID: 38713284 [TBL] [Abstract][Full Text] [Related]
7. Integrative Analysis of miRNAs Identifies Clinically Relevant Epithelial and Stromal Subtypes of Head and Neck Squamous Cell Carcinoma. Holt J; Walter V; Yin X; Marron D; Wilkerson MD; Choi HY; Zhao X; Jo H; Hayes DN; Ko YH Clin Cancer Res; 2021 Feb; 27(3):831-842. PubMed ID: 33148669 [TBL] [Abstract][Full Text] [Related]
8. A novel CAF-cancer cell crosstalk-related gene prognostic index based on machine learning: prognostic significance and prediction of therapeutic response in head and neck squamous cell carcinoma. Xu Y; Li J; Wang J; Deng F J Transl Med; 2024 Jul; 22(1):645. PubMed ID: 38982511 [TBL] [Abstract][Full Text] [Related]
9. EGFR Alterations Influence the Cetuximab Treatment Response and c-MET Tyrosine-Kinase Inhibitor Sensitivity in Experimental Head and Neck Squamous Cell Carcinomas. Nelhűbel GA; Cserepes M; Szabó B; Türk D; Kárpáti A; Kenessey I; Rásó E; Barbai T; Hegedűs Z; László V; Szokol B; Dobos J; Őrfi L; Tóvári J Pathol Oncol Res; 2021; 27():620256. PubMed ID: 34257586 [No Abstract] [Full Text] [Related]
10. Ovarian cancer-derived copy number alterations signatures are prognostic in chemoradiotherapy-treated head and neck squamous cell carcinoma. Essers PBM; van der Heijden M; Vossen D; de Roest RH; Leemans CR; Brakenhoff RH; van den Brekel MWM; Bartelink H; Verheij M; Vens C Int J Cancer; 2020 Sep; 147(6):1732-1739. PubMed ID: 32167160 [TBL] [Abstract][Full Text] [Related]
11. Integrative single-cell and bulk transcriptomes analyses reveals heterogeneity of serine-glycine-one-carbon metabolism with distinct prognoses and therapeutic vulnerabilities in HNSCC. Wang L; Yang R; Kong Y; Zhou J; Chen Y; Li R; Chen C; Tang X; Chen X; Xia J; Chen X; Cheng B; Ren X Int J Oral Sci; 2024 Jun; 16(1):44. PubMed ID: 38886346 [TBL] [Abstract][Full Text] [Related]
12. Cao CH; Liu R; Lin XR; Luo JQ; Cao LJ; Zhang QJ; Lin SR; Geng L; Sun ZY; Ye SK; Yu ZY; Shi Y; Xia X Int J Biol Sci; 2021; 17(7):1744-1756. PubMed ID: 33994859 [TBL] [Abstract][Full Text] [Related]
13. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma. Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment. Li ZX; Zheng ZQ; Wei ZH; Zhang LL; Li F; Lin L; Liu RQ; Huang XD; Lv JW; Chen FP; He XJ; Guan JL; Kou J; Ma J; Zhou GQ; Sun Y Theranostics; 2019; 9(25):7648-7665. PubMed ID: 31695792 [TBL] [Abstract][Full Text] [Related]
15. Spatial transcriptomics reveal tumor microenvironment and SLCO2A1 correlated with tumor suppression in hypopharyngeal squamous cell carcinoma. Li C; Xu C; Guan R; Jiao R; Wang Y; Cui C; Cao S; Chang F; Wei R; Li Z; Liu Z; Gross ND; Li G; Li W; Wei D; Lei D Int Immunopharmacol; 2024 Dec; 142(Pt B):113243. PubMed ID: 39340989 [TBL] [Abstract][Full Text] [Related]
16. CELSR3 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment. Wu Z; Zhu Z; Wu W; Hu S; Cao J; Huang X; Xie Q; Deng C Eur Arch Otorhinolaryngol; 2024 Jun; 281(6):3143-3156. PubMed ID: 38507078 [TBL] [Abstract][Full Text] [Related]
17. Multi-omic analysis and validation reveal ZBP1 as a potential prognostic and immunotherapy-related biomarker in head and neck squamous cell carcinoma. Li Y; Wang N; Yang G J Stomatol Oral Maxillofac Surg; 2024 Sep; 125(4S):101901. PubMed ID: 38688403 [TBL] [Abstract][Full Text] [Related]
18. Identification of PANoptosis-related biomarkers and analysis of prognostic values in head and neck squamous cell carcinoma. Yang P; Huang G; Li Y; Yu L; Yin Z; Li Q Sci Rep; 2024 Apr; 14(1):9824. PubMed ID: 38684755 [TBL] [Abstract][Full Text] [Related]
19. TAM family receptors in conjunction with MAPK signalling are involved in acquired resistance to PI3Kα inhibition in head and neck squamous cell carcinoma. Ruicci KM; Meens J; Plantinga P; Stecho W; Pinto N; Yoo J; Fung K; MacNeil D; Mymryk JS; Barrett JW; Howlett CJ; Boutros PC; Ailles L; Nichols AC J Exp Clin Cancer Res; 2020 Oct; 39(1):217. PubMed ID: 33059733 [TBL] [Abstract][Full Text] [Related]
20. Single-Cell Molecular Profiling of Head and Neck Squamous Cell Carcinoma Reveals Five Dysregulated Signaling Pathways Associated With Circulating Tumor Cells. Stucky A; Viet CT; Aouizerat BE; Ye Y; Doan C; Mundluru T; Sedhiazadeh P; Sinha UK; Chen X; Zhang X; Li SC; Cai J; Zhong JF Cancer Control; 2024; 31():10732748241251571. PubMed ID: 38869038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]